Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations
Related Posts
Kanis JA, Johansson H, Harvey NC, Lorentzon M, Cauley JA, Crandall CJ, Huisman M, Khosla S, Kwok T, Mellström D, Orwoll ES, van Schoor NM,[...]
Okwuosa I, Kumar A, Choi SM, Kamath M, Vellanki S. Breaking Barriers to Transplantation: Desensitization with Daratumumab in Peripartum Cardiomyopathy. Can J Cardiol. 2026 Apr[...]
Sen H, Ni AY, Cooper AN, Limerick G, Cardenas-Rojas A, Mahendram S, Osman SK, Radlicz C, Tram J, Teramoto M, Kanjanapanang N, McCormick ZL, Conger[...]